EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases

Abdulmunir Azizy iD, Izzet Dogan iD, Serap Yucel, Irmak Duru Subasi, Mustafa Bozkurt, Onur Dulgeroglu iD, Ali Arican, Ibrahim Yildiz, Cihan Uras

Cancers · 28.05.2026 · 18 (11) · 1760

DOI: 10.3390/cancers18111760 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.05.2026. Verfasst von Abdulmunir Azizy und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul 34093, Turkey. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer with isolated bone metastases at initial diagnosis represents a clinically distinct metastatic phenotype, often associated with more indolent biology and relatively favorable outcomes compared with visceral metastatic disease. The survival impact of resecting the intact primary breast tumor in de novo metastatic breast cancer remains controversial. In this study, we evaluated the association between primary breast surgery and overall survival (OS), defined as the time from diagnosis to death attributable to breast cancer, in patients presenting with isolated bone metastatic breast cancer.

Methods

We performed a retrospective population-based cohort study using the Surveillance, Epidemiology, and End Results (SEER) database. Because the SEER variable for bone metastasis at diagnosis is available from 2010 onward and HER2-defined subtype information is available in the modern SEER era, the effective study period was defined as 2010–2021 rather than the full 2000–2021 SEER release period. Patients with breast cancer and isolated bone metastases at presentation, without evidence of lung, liver, brain, or other distant metastatic sites at diagnosis, were included. Demographic and clinicopathological variables, including age, sex, race, biologic subtype, histology, chemotherapy, radiotherapy, and primary breast surgery, were analyzed. Overall survival (OS), defined as the time from diagnosis to death attributable to breast cancer, was estimated using Kaplan–Meier methods and compared using the log-rank test. Independent prognostic factors were evaluated using multivariable Cox proportional hazards modeling.

Results

A total of 6500 eligible patients were identified. Surgery of the primary breast tumor was performed in 1513 (23.3%) patients, and 62.8% received chemotherapy. Five-year overall survival (OS) was significantly higher among patients who underwent surgery than among those who did not undergo surgery (59.5% vs. 38.6%; p < 0.001). In multivariable analysis, primary breast surgery remained independently associated with improved OS (hazard ratio [HR] 0.54, 95% CI 0.48–0.62; p < 0.001). Age, histology, chemotherapy, radiotherapy, and biologic subtype were also associated with prognosis. Sex was not significant in the unadjusted analysis (p = 0.188), and the multivariable sex finding was interpreted cautiously because only 96 men were included.

Conclusions

In this population-based cohort of patients with de novo breast cancer and isolated bone metastases, primary breast surgery was associated with improved survival among selected patients. However, this association should not be interpreted as causal, given the inherent limitations of observational registry data, including treatment selection, potential immortal-time bias, unmeasured metastatic burden, performance status, systemic therapy type and response, and local symptom burden, which are not fully captured in SEER. These findings support careful multidisciplinary consideration of local therapy in selected patients, while emphasizing the need for confirmation in prospectively designed studies.

Schlagwörter

Stichwörter der Autor:innen

breast cancerisolated bone metastasesprimary breast surgeryprognosis

Autor:innen und Institutionen

  • Department of Medical Oncology, Istanbul University Institute of Oncology, Istanbul 34093, Turkey.
  • Department of Medical Oncology, Acibadem Healthcare Group, Istanbul 34642, Turkey.
  • Department of Radiation Oncology, Acibadem Research Institute of Senology, Istanbul 34752, Turkey.
  • Department of Breast Radiology, Acibadem University Atakent Hospital, Istanbul 34303, Turkey.
  • Department of Medical Oncology, Acibadem University Atakent Hospital, Istanbul 34303, Turkey.
  • Department of General Surgery, Acibadem University Atakent Hospital, Istanbul 34303, Turkey.

ORCID-Profile: Abdulmunir Azizy, Izzet Dogan, Onur Dulgeroglu

Zitieren

APA

Azizy, A., Dogan, I., Yucel, S., Subasi, I. D., Bozkurt, M., Dulgeroglu, O., Arican, A., Yildiz, I., & Uras, C. (2026). Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases. Cancers, 18(11), 1760. https://doi.org/10.3390/cancers18111760

Vancouver

Azizy A, Dogan I, Yucel S, Subasi ID, Bozkurt M, Dulgeroglu O, et al. Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases. Cancers. 2026;18(11):1760. doi:10.3390/cancers18111760

BibTeX
@article{Azizy2026,
  author = {Azizy, Abdulmunir and Dogan, Izzet and Yucel, Serap and Subasi, Irmak Duru and Bozkurt, Mustafa and Dulgeroglu, Onur and Arican, Ali and Yildiz, Ibrahim and Uras, Cihan},
  title = {Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1760},
  doi = {10.3390/cancers18111760}
}
Kostenlos starten →